Virtual Reality for Preoperative Anxiety in Interventional Cardiology (No PANIC)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04242563 |
Recruitment Status :
Completed
First Posted : January 27, 2020
Last Update Posted : May 19, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Anxiety | Other: VIRTUAL REALITY | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 156 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Virtual Reality for Preoperative Anxiety in Interventional Cardiology |
Actual Study Start Date : | February 2, 2020 |
Actual Primary Completion Date : | July 12, 2021 |
Actual Study Completion Date : | July 12, 2021 |
Arm | Intervention/treatment |
---|---|
No Intervention: CONTROL GROUP
No virtual reality
|
|
Experimental: INTERVENTION GROUP
Patient equipped with Virtual reality in transfer room.
|
Other: VIRTUAL REALITY
Patient equipped with virtual reality in transfer room |
- Effectiveness of virutal reality on the management of preoperative anxiety measured by heart rate variability in interventional cardiology room in patient awaiting coronarography [ Time Frame: Time 1 : 60 minutes ]Heart rate variability during 20 minutes by a heart rate monitor in transfer room
- Evaluation of anxiety level in patient awaiting coronarography [ Time Frame: TIme 1 : 60 minutes, Time 2 : 120 minutes ]The Analogical Self-Assessment Scale for Preoperative Anxiety (0 - no anxiety to 10 - uncontrollable anxiety)
- Patient satisfaction on the global care in the coronary angiography room [ Time Frame: Time 3 : 180 minutes ]Patient satisfaction questionnaire
- Impact of virtual reality on coronarography intervention duration [ Time Frame: Time 2 : 120 minutes ]Intervention duration (in minutes)
- Impact of virtual reality on coronarography irradiation dose [ Time Frame: Time 2 : 120 minutes ]Irradiation dose (in Gy.cm²)
- Impact of virtual reality on coronarography scopy time [ Time Frame: Time 2 : 120 minutes ]scopy time (in minutes)
- Impact of virtual reality on administration of analgesic and anxiolytic drug peri and per coronarography procedure [ Time Frame: Time 2 : 120 minutes ]administration of analgesic and anxiolytic drug peri and perprocedure (drug name and dose)
- Impact of virtual reality on rate and success of coronarography procedure [ Time Frame: Time 2 : 120 minutes ]number and success of PCI

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Major male or female patient
- Coronarography procedure programmed for exploration of coronary artery disease following a positive ischemia test, realized in ambulatory
- Patient who has given written consent to participate in the study
Exclusion Criteria:
- Arrhythmia patient and / or patient with a pacemaker
- Hemodynamic instability
- Patient who has already had coronarography
- Prior revascularization by coronary bypass
- End-stage renal disease (Creatinine clearance <30 ml / min),
- Allergy to iodine contrast agent
- Blind or visually impaired patient (high degree)
- Deaf or hard of hearing patient
- Patient with claustrophobia or unable to wear a mask over the eyes
- Patient whose physical or psychological state could compromise obtaining informed consent and compliance with protocol requirements
- Patient under administrative or judicial supervision
- Foreign patient who does not understand French
- Major patient protected by law (article L1121-8 and L1121-5)
- Pregnant or lactating patient
- Patient not affiliated with social security

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04242563
France | |
Grenoble University Hospital | |
Grenoble, France, 38043 |
Responsible Party: | University Hospital, Grenoble |
ClinicalTrials.gov Identifier: | NCT04242563 |
Other Study ID Numbers: |
38RC19.116 |
First Posted: | January 27, 2020 Key Record Dates |
Last Update Posted: | May 19, 2022 |
Last Verified: | April 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
interventional cardiopathy preoperative anxiety virtual reality |
Anxiety Disorders Mental Disorders |